Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond

Surya Pandey,Meghan E. Cholak,Rishita Yadali,Jeffrey A. Sosman,Marie-Pier Tetreault,Deyu Fang,Seth M. Pollack,Sacha Gnjatic,Rebecca C. Obeng,H. Kim Lyerly,Adam M. Sonabend,José A. Guevara-Patiño,Lisa H. Butterfield,Bin Zhang,Holden T. Maecker,I. Caroline Le Poole

DOI: https://doi.org/10.3390/cancers16030475

2024-01-24

Cancers

Abstract:As part of a symposium, current and former directors of Immune Monitoring cores and investigative oncologists presented insights into the past, present and future of immune assessment. Dr. Gnjatic presented a classification of immune monitoring technologies ranging from universally applicable to experimental protocols, while emphasizing the need for assay harmonization. Dr. Obeng discussed physiologic differences among CD8 T cells that align with anti-tumor responses. Dr. Lyerly presented the Soldano Ferrone lecture, commemorating the passionate tumor immunologist who inspired many, and covered a timeline of monitoring technology development and its importance to immuno-oncology. Dr. Sonabend presented recent achievements in glioblastoma treatment, accentuating the range of monitoring techniques that allowed him to refine patient selection for clinical trials. Dr. Guevara-Patiño focused on hypoxia within the tumor environment and stressed that T cell viability is not to be confused with functionality. Dr. Butterfield accentuated monitoring of dendritic cell metabolic (dys)function as a determinant for tumor vaccine success. Lectures were interspersed with select abstract presentations. To summarize the concepts, Dr. Maecker from Stanford led an informative forum discussion, pointing towards the future of immune monitoring. Immune monitoring continues to be a guiding light towards effective immunotherapeutic strategies.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to optimize and standardize immunomonitoring techniques in order to more accurately evaluate the effectiveness of immunotherapy in cancer and other diseases. Specifically, by reviewing the content of the Immunological Evaluation Symposium held in Chicago in October 2023, the paper explores the following aspects:

1. **Standardization of immunomonitoring techniques**: The paper emphasizes the importance of standardization and coordination of immunomonitoring techniques among different laboratories to ensure the consistency and comparability of results. This includes the classification of different techniques (such as generally applicable techniques and experimental protocols), and how to achieve standardization through the sharing of standard operating procedures (SOPs), cross - laboratory testing, and the development of consensus SOPs.

2. **Multi - omics analysis of immune responses**: It discusses how to use multi - omics methods (such as genomics, transcriptomics, proteomics, etc.) and cross - trial analysis to identify biomarkers related to treatment responses. These methods are helpful for understanding the tumor - immune microenvironment and guiding the design and implementation of clinical trials.

3. **Biomarkers for predicting immunotherapy responses**: The paper explores the roles of multiple biomarkers in predicting patients' responses to immunotherapy, including the proliferation of CD8 T cells, T - cell receptor (TCR) sequencing, and the presence of stem - cell - like CD8 T cells in the tumor microenvironment. These biomarkers are helpful for improving patient screening and prognostic assessment.

4. **Application of immunomonitoring in clinical trials**: The paper presents several specific clinical trial cases, showing how immunomonitoring can help define treatment effects, especially in checkpoint inhibitor therapy. These cases include using CyTOF data to identify diagnostic or prognostic factors, and comparing the effects of different treatment methods through CAR T cells and bispecific T - cell engagers.

5. **Technological advancements**: Finally, the paper also discusses the impact of technological advancements on immunomonitoring, including the application of synthetic melanin particles, the study of the interaction between tissue stem cells and immune cells, and the application of single - cell analysis techniques in the study of the immune landscape of rare tumors (such as chordoma).

In summary, this paper aims to promote the standardization and optimization in the field of immunomonitoring by integrating experts' opinions and technological progress, thereby improving the efficacy of immunotherapy in cancer and other diseases.